The Evidence Speaks (December 2022)
Featuring student experiences of suicidal ideation, multimorbidity among TB survivors in B.C., and sugary drinks and social jetlag in adolescents
Read MoreFeaturing student experiences of suicidal ideation, multimorbidity among TB survivors in B.C., and sugary drinks and social jetlag in adolescents
Read MoreSeptember's edition includes severity of the Omicron versus Delta COVID-19 variants, pre- and in-hospital factors that impact outcomes of cardiac arrest, and long-acting contraceptive use among Ugandan women
Read MoreThis edition highlights research evaluating patient involvement in clinical trial design, detecting prior COVID-19 infections, and the effect of wildfires on respiratory health
Read MoreThis edition includes emergency contraception use in B.C., overdose following incarceration, and risk factors for hospitalization with COVID
Read MoreThis edition includes the association between TB and depression, emergency physician's attitudes and competencies towards suicidal ideation, and blood pressure monitoring in pregnancy
Read MoreAs we enter into another exciting year of improving health outcomes for B.C. and beyond, we’re reflecting on some of the CHÉOS research from the past year
Read MoreThis edition includes cannabis use in women with pelvic pain, the association between HPV vaccination and STIs, and anticoagulation for dialysis patients with atrial fibrillation
Read MoreThe WHO-funded study shows that dolutegravir is the optimal choice for first-line treatment of HIV
Read MoreDr. Ehsan Karim shares his expert opinion on how statistical modeling and machine learning could help overcome research limitations
Read MoreThe latest edition summarizes some of the latest research from CHÉOS Scientists Drs. Sarah Munro, Andrea Veljkovic, Anita Palepu, Ehsan Karim, and Anne Gadermann
Read More